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ORIGINAL ARTICLE 
TITLE: Characterization of clinical and electrocardiographic findings in a youth 
population  
Vilardell P. MS, Brugada R. MD PhD, Falces C. MD PhD, Puigdevall Ma. MD, Brugada J. MD PhD 
ABSTRACT 
Introduction: Resting 12-lead electrocardiogram (ECG) has been employed in the evaluation 
of young asymptomatic subjects to detect pre-existing heart diseases. Although the incorporation of 
routine ECG remains controversial, there is increasing evidence that cardiomyopathies and ion 
channelopathies show ECG changes as the initial manifestation. The causes of sudden cardiac death in 
young people show a significant geographical variation. We aim to determine the prevalence and 
spectrum of ECG findings in a youth population.  
Methodology: From May 2010 to April 2013, a total of 976 young secondary school students (mean 
age, 14 years; range, 13-15) underwent voluntary medical screening that included a resting 12-lead ECG 
and structured clinical survey. Subjects with abnormal ECG findings were classified into two groups: 
major ECG findings group, which fulfilled a pre-specified checklist to screen for principal structural and 
electrical cardiopathies, and minor ECG findings group showing other ECG changes. The major ECG 
findings group was referred for secondary diagnostic tests at a tertiary institution.   
Results: Of the 976 subjects screened, 252 (25.82%; CI95%, 23.17-28.66) had ECG findings. Of note, 
17 (1.74%) had major findings and 235 (24.08%) had minor findings on ECG. The prevalence of 
cardiovascular pathology within the major ECG findings group was 35.29%. The prevalence of ECG 
abnormalities was significantly higher in males than in females (29% vs 20.9%, P<0.01).  
Conclusions: The prevalence of ECG findings in a youth population was 25.82%. There were 
significant gender differences. The inclusion of universal ECG screening, in addition to medical history, 
may increase the sensitivity of a cardiovascular screening program. Knowledge of the spectrum and 
prevalence of ECG findings and disease conditions would be pivotal in designing customized screening 
programs. 
Keywords: Mass screening, ECG findings, youth population, sudden cardiac death, clinical survey 
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1- INTRODUCTION 
1.1- Background 
Most males and females between 13 and 15 are healthy. These teenagers have 
undergone regular pediatric controls by the National Health System (NHS). However, 
given that in this population a 12-lead electrocardiogram (ECG) and a cardiac clinical 
history are not universally recorded, clinical and/or electrocardiographic findings are 
not documented in a healthy young population.  
There are heart diseases that can cause symptoms such as palpitations, loss of 
consciousness and sudden cardiac death in the young population. Sudden cardiac death 
is the most important clinical manifestation due to the large impact that entails. It is 
defined as an unexpected natural death by cardiac causes, heralded by abrupt loss of 
consciousness during the early acute symptoms
1–3
. When this happens, it is devastating 
for the family and social environment of the patient, because young people are the 
healthiest stratum of the general population
4–6
. Although the incidence of sudden 
cardiac death in young people is not well established, it is estimated to range between 
0.8 and 3.8 per 100.000 person-year
1,5–8
. The strongest evidence is provided by a 
prospective observational study from the region of Veneto (Italy), where an incidence of 
2.3 per 100.000 person-year (2.6 in males / 1.07 in females) was reported
7,9
. Most of 
these epidemiological studies are based on the athletic population, because the risk of 
sudden death is higher in this population compared to non-athletes
10,11
. Recently, 
Marijon et al have reported that the increase  of relative risk in sport-related sudden 
cardiac death in high performance athletes (10-35 years) compared with non-
competitive athletes of the same age is 4.5 times higher
12
. About 25% of sudden cardiac 
deaths in young people occurs during the sports activity
13,14
. 
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Being male is a well-known independent risk factor for sudden cardiac death, both in 
general population, where there is a 3:1 ratio, and in young athletes population, where 
the ratio is even higher (9:1)
2,4–6,11,15
. 
Most sudden cardiac deaths in young people are secondary to pre-existing 
cardiovascular disease
5
. The prevalence of cardiovascular disease in young athletes is 
0.3%
16
. These underlying cardiovascular diseases associated with sudden cardiac death 
are classified into three groups
5,7,11,15
: 
 Electrical cardiac abnormalities, including Wolff-Parkinson-White syndrome 
(WPW), Brugada syndrome (BrS), long QT syndrome (LQTS) and short QT 
syndrome (SQTS). 
 Structural cardiac abnormalities, mainly including hypertrophic 
cardiomyopathy (HCM) and arrhythmogenic right ventricular dysplasia 
(ARVD), but also Marfan syndrome, congenital anomalies of the coronary 
arteries, mitral valve prolapse and aortic stenosis have been reported. 
 Other acquired cardiac abnormalities, including myocarditis and premature 
atherosclerotic coronary artery disease, among others. 
The causes of sudden cardiac death in young people have shown a significant 
geographic variation. While in Italy the leading cause of sudden cardiac death among 
young athletes is ARVD, in the U.S. the main cause is HCM
14,17–20
. These cardiac 
diseases aforementioned usually remain asymptomatic and therefore often go unnoticed. 
So, it is necessary to use diagnostic tests that allow us to identify those patients with a 
risk of sudden cardiac death predisposition within an apparently healthy population. 
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The baseline 12-lead ECG can orientate the diagnosis of most of cardiac diseases listed 
above. This test has shown high sensitivity and specificity for the detection of these 
cardiac diseases in populations of young individuals
8,10
. 
About 95% of individuals with HCM and 80% of patients with ARVD showed 
electrocardiographic findings. As for individuals with LQTS, electrocardiographic 
findings are identified with a 12-lead ECG in 85-90% of these patients
21–23
. The 
baseline 12-lead ECG is a test with a high negative predictive value (99.98%) and, 
therefore, excludes pre-existing cardiovascular diseases if normal
10
. A common 
objection to this diagnostic test is the supposed high rate of false positives, resulting in 
unnecessary additional investigation tests. It should be noted that this false positive rate 
is largely determined by the criteria used to define the electrocardiographic 
abnormality
10
. Thus sense, the current recommendations of the European guidelines for 
interpretation of the electrocardiogram have eliminated the isolated voltage criteria for 
left ventricular hypertrophy (LVH) as a criteria which requires additional diagnostic 
evaluations, thus reducing the false positive rate
10,24–26
. 
Corrado et al have compiled a table that correlates the most frequent pre-existing 
cardiovascular diseases and their associated electrocardiographic findings in athletes
8
. 
The electrocardiographic screening together with a structured survey for clinical data in 
large populations conducted in several countries has proved useful for identifying young 
asymptomatic people with pre-existing cardiac diseases
9,27
. 
It has been shown that electrocardiographic screening is more sensitive than clinical 
history and physical examination to identify patients at risk of sudden cardiac death
28,29
. 
Corrado et al have reported that the 12-lead ECG has 77% more chances to detect HCM 
than the clinical history and physical examination
30
.  
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Only 7% of young individuals with sudden cardiac death had a positive family history, 
and in <1% of those the anamnesis and physical examination confirmed the diagnosis of 
sudden cardiac death
31
. 
The implementation of electrocardiographic screening program prior to sports activity 
has resulted in a 89% reduction in the annual incidence of sudden cardiac death (3.6 per 
100.000 person-year in the pre-screening stage to 0.4 per 100,000 person-year at 
present) in the Italian region of Veneto
6,8,19,20,30,32
. The electrocardiogram screening in 
young adults have demonstrate that is cost-effective in multiple studies
8,10,28,30,33
. 
Recently, Lesslie et al have reported that performing an electrocardiogram screening for 
young people of 14 years old is cost-effective
14,31
. 
1.2- Justification of the project 
The prevalence of symptoms and electrocardiographic findings in young people is 
unknown especially because it occurs in the healthiest stratum of the population. We 
believe that conducting 12-lead ECG universally in males and females between 13 and 
15 years, in combination with a structured clinical survey will allow (i) determining the 
prevalence of electrocardiographic and clinical findings that can warn on the possibility 
of underlying cardiovascular disease, (ii) characterising the main electrocardiographic 
findings and clinical manifestations of this population and (iii) establishing early 
diagnosis of potentially serious pre-existing cardiovascular diseases. 
Furthermore, the impact of sudden cardiac death, while statistically small, has an effect 
greater than other causes of death, mainly on the family and social relations of the 
victims. This is due to the apparent suddenness and unexpectedness in an individual 
who was previously considered in the best of health and consequently in no danger.  
In conclusion, we considered that further studies on this subject are more than justified.  
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2- HYPOTHESIS 
Mass screening for young people aged between 13 and 15 years, consisting of an 
electrocardiogram and a structured clinical survey, would allow early identification of 
electrocardiographic findings and/or symptoms in this population. The characterization 
of these findings will identify the prevalence of those in the population studied and 
those suspected of pre-existing cardiovascular disease. Because most of these 
underlying cardiovascular pathologies are asymptomatic, we expect to find a higher 
percentage of electrocardiographic abnormalities than clinical alterations. According to 
the studies cited in the bibliography, we hope to find a greater number of 
electrocardiographic abnormalities in males. 
A more comprehensive cardiac study of patients with major electrocardiographic 
findings and/or suspected heart disease by clinical history collected through structured 
survey would permit early detection of underlying cardiovascular diseases. 
The data obtained from the structured clinical survey and electrocardiography could be 
related to see potential associations. We would hope to find associations between 
electrocardiographic findings and other variables: gender; family history of sudden 
cardiac death; and clinical history of palpitations, loss of consciousness, seizures and 
chronic medication. 
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3- OBJECTIVES 
Principal objective 
- To ascertain the prevalence of clinical and electrocardiographic findings in a 
general healthy population between 13 and 15 years.  
Secondary objectives 
- To ascertain the prevalence of pre-existing cardiovascular disease in patients 
with major electrocardiographic findings and/or suspected cardiovascular 
disease by clinical history collected through structured survey.  
- To analyse the association between electrocardiographic findings and clinical 
characteristics, as well as the association between electrocardiographic findings 
and gender.  
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4- MATERIALS AND METHODS 
4.1- Study design 
This report is based on a pilot project started in May 2010 in the Pla de l’Estany county. 
The whole project was divided into two phases: the first phase consisted of a descriptive 
cross-sectional population-based study where an electrocardiographic screening was 
carried out to identify the main clinical and/or electrocardiographic findings of the 
sample group. In all participants it was required a signed parental consent form before 
participating.  (This document is shown in Annex 1 [parental consent form]). The 
second phase consisted of a prospective follow-up of those individuals identified with 
relevant clinical history and/or major electrocardiographic findings. 
This project was approved by the Ethics Committee of Clinical Research (CEIC) of the 
Hospital Clinic of Barcelona. (See in Annex 2 [resolution of Ethics Committee]). 
Participation in the project was entirely voluntary and each individual was able to drop-
out or reject their involvement in the study at any time of their choosing. The decision 
to participate or not will not influence the quality of medical care that every individual 
is entitled to receive. Electrocardiograms and clinical surveys were coded to ensure the 
protection of the identity of individuals. The researchers who analyzed study variables 
were blinded to the personal data of participants. 
The researchers were committed to follow the ethical principles established in the 
Declaration of Helsinki
34
. Likewise, the research team was committed to ensure 
compliance with the principles set out in the Llei Orgànica de Caràcter Personal 
15/1999 and to facilitate their rights of access, rectification, cancellation and opposition 
to the data and/or electrocardiograms. 
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4.2- Study population 
The study population was made up of young people registered during the 2
nd
 year of 
obligated secondary education (ESO) in secondary schools of Pla de l’Estany county, in 
the academic years from 2009/2010 to 2012/2013. Along this period, 1.212 students 
were enrolled in these secondary schools. The centers of Pla de l’Estany county are: 
secondary schools of Pere Alsius i Torrent, Josep Brugulat, Pla de l’Estany and Casa 
Nostra. 
4.3- Sampling 
The research team for this study used a non-probabilistic volunteer sample. All 1.212 
students enrolled in secondary schools of Pla de l’Estany county were the target 
population, and we aimed to obtain a minimum of 70% participation of that population 
to get a representative sample.  
4.4- Instrumentalization and study variables  
The material used for the study was: 
 Laptop with a USB extension composed of 10 electrodes, a processor which 
detects and transmits the electrical information of the heart, and specific 
software that record the electrocardiograms, called CardioSoft ®. Along these 
four years, the same computer laptop from the medical school of University of 
Girona (UdG) has been used to perform the ECG recording.   
 10 patches / volunteer with alcohol and swabs to attach the electrodes to the 
specified parts of the body of the young people. 
 Paper, ink and envelopes for briefing documents by the project, parental consent 
form, clinical surveys and medical reports to give to each individual. 
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The variables studied were: 
Outcome 
 Electrocardiographic findings 
o Major electrocardiographic findings: significant findings requiring 
additional cardiac follow-up to rule out underlying cardiovascular 
disease. (These electrocardiographic findings are summarized in Table 1) 
o Minor electrocardiographic findings: findings without pathological 
significance or that are simply variants of normality. (See in Table 1)  
Associated variables o covariates  
 Date of birth 
 Sex: male / female 
 Electrocardiographic measurements: 
o Heart rate: number of beats per minute 
o QRS: duration of QRS complex in milliseconds (ms) 
o QT: duration between Q wave and T wave in ms 
o QTc: corrected QT segment according Bazzett formula (QTc= QT/√RR) 
o P: duration of P wave in ms 
o PR: duration between P wave and R wave in ms 
o RR: duration between R waves of different QRS complexes in ms 
o PP: duration between P wave of different QRS complexes in ms 
 Medical history: clinical data recorded using a structured survey based with 12-
Point AHA Questionnaire
20
. Family history of sudden cardiac death, medical 
history of palpitations, loss of consciousness, seizures and chronic medication 
were asked in the structured survey. (See Annex 3 [structured clinical survey]). 
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4.5- Methodology  
Every student of 2nd ESO in Pla de l’Estany county received a letter with a synopsis of 
the project, a parental consent form and a clinical survey which assessed personal and 
family medical history of the individual. These documents are shown in Annex 1 
[parental consent form] and Annex 3 [structured clinical survey]. The letter was sent by 
the tutors of the different secondary schools of Pla de l’Estany county. 
The Educational Department of the City of Banyoles coordinated the timetable of all 
secondary schools with the medical team, consisting of two nurses and two medical 
students to visit each school in accordance with their regular timetable. (See in Annex 4 
[work schedule]). 
On day of visit to the school, each student had a signed parental consent form and filled 
out the clinical survey. The medical team reviewed the clinical survey answers and 
performed a 12-lead resting ECG, that was recorded in supine position, according good 
clinical practice recommendations for performing electrocardiograms
35
. All ECG were 
recorded at the different secondary schools of Pla de l’Estany county. Only these ECG 
that the researchers considered low-quality ECG were repeated at the primary health 
center of Banyoles.  
The electrocardiograms were analyzed initially by the student researcher (PV) and were 
reviewed in their entirety by a cardiologist (JB) with extensive experience in pediatric 
cardiology. Only if the researchers identified a major electrocardiographic finding 
and/or suspected heart disease by clinical history collected through structured survey, a 
more comprehensive cardiac study of these patients were performed in a tertiary center 
by a specialized clinician (MaP). Additional diagnostic tests were requested according 
hospital’s clinical practice guidelines. (See flowchart of the ECG screening in Figure 1). 
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4.6- Electrocardiographic measurements  
All electrocardiograms were recorded digitally by the program CardioSoft ® from a 
laptop provided by the medical school the UdG. All participants’ data were introduced 
in the program CardioSoft ® with a randomized code. During the recording 
electrocardiograms were kept with EXA format. These documents were transformed 
into PDF format to perform the analysis and electrocardiographic study variables were 
entered in a database in Excel format. The variables entered in the database were as 
follows: 
 Identifying data : code ID / date of birth / gender 
 Electrocardiographic variables: heart rate (bpm) / QRS (ms) / QT (ms) / QTc 
(ms) / P (ms) / RR (ms) / PP (ms) / PR (ms) / electrocardiographic findings (See 
in Table 3). 
 Clinical data: family history of sudden cardiac death / medical history of 
palpitations, loss of consciousness, seizures and chronic medication. 
To facilitate the analysis, electrocardiographic findings were divided into two 
categories: major findings and minor findings. Table 1 shows the ECG findings were 
included in both groups. This classification rely on recommendations of the European 
Society of Cardiology (ESC)
7,8,24
. All electrocardiographic variables were continuous 
variables, and all clinical variables were dichotomous variables. About the 
electrocardiographic findings (outcome of the study) was a categorical variable 
(normality, minor electrocardiographic finding and major electrocardiographic finding).  
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4.7- Statistical analysis  
The estimated prevalence of electrocardiographic findings in the study population was 
ascertained with a confidential interval of 95%. Also, a confidential interval of 95% was 
used to ascertain the prevalence of underlying cardiovascular disease on patients with 
major electrocardiographic findings and/or suspected cardiovascular disease by clinical 
history collected through structured survey. 
All electrocardiographic variables were considered continuous variables. We estimated 
the average, standard deviation, maximum value and minimum value of each 
electrocardiographic variable. (See in Table 2).  
A binary logistic regression model to assess the association between the outcome 
(electrocardiographic findings) and associated variables (family history, history of 
palpitations, loss of consciousness, chronic medication and sex) was used for statistical 
analysis. 
To facilitate the analysis, the response variable was grouped as if it was a dichotomous 
variable (electrocardiographic findings vs normality). All associated variables (clinical 
data and gender) were also treated as dichotomous variables. 
In statistical analysis we used the Wald contrast. Moreover, the estimated odds ratios 
(OR) were calculated for each covariate and their 95% CI. In this study, those variables 
statistically significant were considered if p value <0.05. The statistical package used in 
this study was SPSS. 
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5- RESULTS 
5.1- Demographic data 
Total participation in our study was 80.53% (976 individuals). The participation of 
enrollment by years and sex is shown in Table 3. As for students who did not 
participate, only 12 individuals (0.99% of the total population) replied formally in the 
negative with the parental consent form. The remainder (94.95% of students who did 
not participate in the study) did not reply formally with the parental consent form.  
According to gender variable, rates of enrollment were 50.61% for females (n = 494) 
and 49.39% for males (n = 482). (See in Table 3). 
5.2- Clinical data 
A total of 222 individuals (22.75%) reported a positive family history in the structured 
clinical survey. In the section on personal history: 160 individuals (16.39%) reported 
palpitations, 105 individuals (10.76%) had a clinical history of loss of consciousness, 
and only 18 (1.84%) had experienced seizures. 9.32% of the study population (91 
individuals) reported that they were using some kind of chronic medication. The most 
common chronic medication included: 
 Respiratory disorders: 45 individuals (4.61%) 
 Attention deficit hyperactivity disorder (ADHD): 18 individuals (1.84%) 
 Thyroid-related disorders: 6 individuals (0.61%) 
 Diabetes mellitus type I: 4 individuals (0.41%) 
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5.3- Electrocardiographic findings 
Electrocardiographic findings were identified in a total of 252 individuals (25.82%) 
(23.17, 28.66 95% CI). Of these, 235 patients (24.08%) showed minor 
electrocardiographic findings and only 17 patients (1.74%) showed major 
electrocardiographic findings requiring additional diagnostic tests in a tertiary 
institution.  
The average heart rate of the target population was 80.07 bpm, with a maximum value 
of 143 bpm, minimum value of 44 bpm and standard deviation of 15.24. (Table 2 
summarizes all ECG variables). About the minor electrocardiographic findings, the 
third most frequent were isolated QRS voltage criteria for left ventricular hypertrophy 
(6.05% of sample population), sinus bradycardia (5.53% of sample population) and 
early repolarization (2.97% of sample population). These three common abnormalities 
included more than 60% of all minor electrocardiographic findings. (Table 2 shows all 
ECG findings). 
Of the 17 individuals with major electrocardiographic findings, additional tests showed 
that 6 of those patients (35.29%) (17.31, 58.70 95% CI) had been diagnosed with pre-
existing cardiovascular disease. These underlying cardiovascular pathologies were: a 
bivalve aortic valve, a coronary fistula without hemodynamic repercussion, a mitral 
valve prolapse, two bifascicular blocks  and a patient with criteria of left ventricular 
hypertrophy, right bundle branch block (RBBB) and short PR interval. (See in Table 4). 
In conclusion, pre-existing cardiovascular diseases were identified in 0.61% (0.28, 1.33 
95% CI) of the target population. 
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5.4- Statistical analysis results 
The prevalence of electrocardiographic findings was significantly higher in the group of 
males where the prevalence was 29%, compared to the female group where the 
prevalence was 20.9%. This association was statistically significant (p value = 0.003). 
The estimated odds ratio (OR) of this covariate was 1.554 (1.159, 2.083 95% CI). 
No significant associations were found in other covariates, see in Figure 2. Table 5 
show detailed statistical analysis of the other covariates. 
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6- DISCUSSION 
6.1- Previous studies and interpretation of the results 
The main observation of this pilot study is that the prevalence of electrocardiographic 
findings is 25.82% in this healthy youth population. However, only 17 (1.74%) required 
additional diagnostic tests because they had shown major electrocardiographic findings 
and/or suspected cardiovascular disease through clinical history collected in structured 
survey. Differences of the target population and the methodology of the study could 
explain the disparity of the results if it is compared with other similar studies: the ECG 
screening in trained athletes was performed by Italian researchers, and showed 
cardiovascular remodeling associated with ECG abnormalities as frequently (up to 
80%) and the uncommon ECG patterns in <5%
26
. In contrast, the Japanese studies 
demonstrate ratios of cardiovascular pathologies between 0.01-0.04% in pupils and 
students, lower than in the Pla de l’Estany county study27,29. In accordance with 
references, ECG findings are especially frequent in the male gender
2,4–6,11,15
.  
In mass screening for heart diseases, it has often been found difficult to judge 
immediately as to whether or not young adults need medical management when they 
have ECG findings. Although most these ECG changes are ‘abnormal’ in a strict 
statistical sense, they do not imply the presence of cardiovascular disease or an increase 
of cardiovascular risk and sudden cardiac death in young adults.  
Underlying cardiovascular diseases found in our study were not the most frequent as 
described in the previous references. While in Italy the leading pre-existing 
cardiovascular disease in young athletes is ARVD, in the U.S. the main cause is 
HCM
14,17–20
. Geographic variations could explain these results.  
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A curious data found in our study was that 52.94% of major electrocardiographic 
findings were identified in the last year of the study (2013). We attributed these results 
as random, because we used same materials, medical team and criteria at the reviewing 
of 12-lead ECG for referral to a specialized clinician during the years of the study.   
To our knowledge, this study is the first to investigate electrocardiogram findings and 
clinical data universally in a healthy young population between 13 and 15 years. 
6.2-Strengths and Limitations 
A high-level participation of 80.53% was obtained. This high participation rate suggests 
that the sample population is similar to the population studied.  
The low prevalence of structural and electrical cardiopathies that cause sudden cardiac 
death in this population has been one of the most important limitations of this project. 
A common limitation of ECG screening is the high rate of false positives, which entails 
unnecessary additional diagnostic tests. It was attempted to solve this problem using the 
criteria of electrocardiographic findings modified from Corrado et al
8
. These criteria 
show clearly which electrocardiographic findings needs additional diagnostic tests and 
which electrocardiographic findings do not. This classification of ECG findings reduces 
patients that have to visit a tertiary institution without pathology, and thereby also 
reducing concurrent family anxiety.  
One of the problems with the screening system is the reliability of the information 
obtained from questionnaires. Secondary school students often answer the questions by 
themselves without consultation with their parents thereby reducing the reliability of the 
questionnaires
27
. It was attempted to solve this problem by requiring the signature of 
student’s parents in the questionnaires which were then checked before ECG recording. 
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6.3- Clinical implications 
The addition of universal ECG screening in combination with a structured clinical 
survey may increase the ability to detect people at risk of sudden cardiac death and to 
meet the primary objective of the screening evaluation: detection of those at risk of 
sudden cardiac death, with the hope of decreasing morbidity, mortality, and/or disease 
progression through early detection, early intervention, and appropriate management.   
22 
 
7- CONCLUSIONS 
The prevalence of electrocardiographic findings in a population of young adults 
between 13 and 15 years old was 25.82%. 
The prevalence of cardiovascular pathology within the group of patients with major 
electrocardiographic findings was 35.29%.  
There is no association between the outcome (ECG findings) and clinical variables such 
as palpitations, loss of consciousness, family history of sudden cardiac death and 
chronic medication. We have found statistically significant association between the 
outcome (ECG findings) and variable gender. Males are 1.554 times more likely to have 
electrocardiographic findings than females. 
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11- TABLES AND FIGURES 
 
Table 1: Classification of electrocardiographic findings 
MINOR ECG FINDINGS  MAJOR ECG FINDINGS 
First degree AV block  ST-T abnormalities 
Sinus bradycardia  Pathologic Q waves 
Isolated QRS voltage criteria for LVH  LBBB 
Early repolarization  Complete RBBB 
Axis deviation (Axis QRS  <30 o >120)  Ventricular premature beats 
Incomplete RBBB  QT interval abnormalities 
Left atrial enlargement  More than 1 minor ECG findings 
Atrial premature beats   
Modified from Corrado et al (8). AV= atrioventricular / LBBB=left bundle branch block / LVH=left 
ventricular hypertrophy / RBBB=right bundle branch block. 
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Table 2: Electrocardiographic variables and findings 
ECG variables Average Standard deviation Max. value Min. value 
QRS 89,25 ms 11.65 126 ms 62 ms 
QT 361,68 ms 32.80 464 ms 266 ms 
QTc 412 ms 30.10 530 ms 296 ms 
P 85,75 ms 12.1 128 ms 45 ms 
PR 136,2 ms 20.37 294 ms 88 ms 
RR 765,6 ms 153.94 1384 ms 422 ms 
PP 765,07 ms 152.56 1360 ms 415 ms 
 
MINOR ELECTROCARDIOGRAPHIC FINDINGS 
ECG Findings n Percentage 
1
st
 Degree AV Block (PR>200ms) 11  1.13% 
Sinus bradycardia (<60 bpm) 54  5.53% 
Early repolarization 29 2.97% 
Axis deviation (Axis QRS  <30 o >120) 27 2.77% 
Incomplete RBBB 13 1.33% 
Left atrial enlargement 21  2.15% 
Atrial premature beats 21 2.15% 
Isolated QRS voltage criteria for LVH 59 6.05% 
MAJOR ELECTROCARDIOGRAPHIC FINDINGS 
ECG Findings n Percentage 
ST-T abnormalities 2  0.21% 
Ventricular premature beats 2  0.21% 
LBBB or complete RBBB 2 0.21% 
QT interval abnormalities 2  0.21% 
More than 1 minor ECG findings 9 0.92% 
AV= atrioventricular / LBBB=left bundle branch block / LVH=left ventricular hypertrophy / 
RBBB=right bundle branch block. 
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Table 3: Annual percentage by years of enrollment and gender 
Years of enrollment Nº of participants Participation (%) Males Females 
2010 254 92,36%  135 (53.15%) 119 (46.85%) 
2011 244 74,84%  118 (48.36%) 126 (51.64%) 
2012 245 78,53%  115 (46.94%) 130 (53.06%) 
2013 233 77,93%  114 (48.93%) 119 (51.07%) 
Total 976 80,53%  482 (49.39%) 494 (50.61%) 
 
 
Figure 1: Flowchart of the electrocardiographic screening 
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Table 5: Statistical analysis results 
Variables OR 95% IC p-value 
Family history 0,91 (0,49 - 1,69) 0,76 
Palpitations 0,85 (0,57 - 1,28) 0,44 
Loss of consciousness 0,99 (0,62 - 1,59) 0,97 
Medication 0,9 (0,54 - 1,94) 0,67 
Gender 1,55 (1,16 - 2,08) <0,01 
 
Figure 2: Statistical signification of OR  
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13- ANNEXES 
13.1- Annex 1 
CONSENTIMIENT INFORMAT 
ESTUDI DE L’ELECTROCARDIOGRAMA EN ALUMNES DE 2º D’ESO AL 
PLA DE L’ESTANY 
 
INFORMACIÓ GENERAL 
Convidem al seu fill/filla a participar en un projecte d’exploració electrocardiogràfica 
en alumnes de 2n d’ESO. Abans de signar aquest consentiment, prengui el temps 
necessari per llegir i comprendre tota la informació. Pregunti al seu metge o a un 
membre del personal mèdic tots els dubtes que tingui sobre aquest estudi i sobre els seus 
drets. Ells estan preparats per contestar totes les seves preguntes. 
Li demanem que llegiu aquest document perquè comprengui aquest estudi i la manera 
en què el seu fill/filla pot participar. Signant aquest document vostè està consentint a la 
participació del seu fill/filla en aquest estudi. 
PROPÒSIT DE L’ESTUDI 
El propòsit de l’estudi és identificar en una població de joves de 2n d’ESO de la ciutat 
de Banyoles (entre 13 i 15 anys) alteracions electrocardiogràfiques causades per un grup 
de malalties cardíaques que potencialment poden causar arítmies cardíaques, pèrdues 
sobtades del coneixement i/o mort sobtada (com la síndrome de Wolf-Parkinson-White, 
la síndrome de Brugada, la síndrome de QT llarg, la síndrome de QT curt, la 
miocardiopatia hipertròfica i la displàsia aritmogènica de ventricle dret). Aquestes 
malalties solen alterar l’electrocardiograma basal, i la seva detecció primerenca redunda 
en la prevenció d’esdeveniments cardíacs malignes, mitjançant la implementació d’un 
tractament mèdic adequat. També li preguntarem al seu fill/filla si ha tingut algun 
símptoma relacionat amb aquestes malalties (com palpitacions, pèrdua del coneixement, 
convulsions) i si hi ha antecedents familiars de les mateixes.  
PROCEDIMENT 
Recollida de dades clíniques i antecedents familiars 
Abans de realitzar l’electrocardiograma, li demanarem al seu fill/filla respondre a un 
petit qüestionari, sobre l’existència de símptomes com pèrdues de coneixement, 
palpitacions (sensació de batecs cardíacs forts i/o ràpids), convulsions en el passat, així 
com també antecedents familiars de mort sobtada en persones joves i presumptament 
sanes (mort brusca en algun familiar menor de 50 anys).  
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Realització de l’electrocardiograma de 12 derivacions 
L’electrocardiograma és el registre no invasiu de l’activitat elèctrica del cor. Per 
realitzar-lo, l’individu ha d’estar recolzat en una llitera, i connectat a un 
electrocardiògraf mitjançant 10 elèctrodes (cables) a la pell: 1 elèctrode en cadascuna de 
les extremitats, i 6 elèctrodes sobre la pell del pit. A continuació es registra 
l’electrocardiograma (procediment que dura aproximadament 1 minut). Realitzar un 
electrocardiograma no produeix cap molèstia ni dolor. A continuació es desconnecten 
els elèctrodes, i el traçat de l’electrocardiograma ha de ser interpretat per un cardiòleg.  
COMUNICACIÓ DE RESULTATS 
Una vegada que l’electrocardiograma sigui informat per un cardiòleg, rebrà vostè un 
informe escrit amb el resultat. 
Si l’electrocardiograma és anormal i/o els símptomes del seu fill/filla fan sospitar una 
malaltia cardíaca, serà derivat a un cardiòleg, per aprofundir l’avaluació del seu fill/filla.   
RISCOS/MOLÈSTIES 
No existeix risc físic, ni molèsties. Per realitzar un electrocardiograma només cal 
connectar uns elèctrodes (cables) als membres i al tòrax, estant recolzat, durant 1 minut.   
BENEFICIS 
La informació obtinguda durant la investigació pot resultar en el diagnòstic precoç 
d’una malaltia cardíaca en el seu fill i la seva família, amb la possibilitat de rebre de 
manera primerenca un tractament adequat. En cas de no tenir cap malaltia, tindrà la 
tranquil·litat que el seu fill/filla pot realitzar activitats físiques sense cap risc per a la 
seva salut. En tot cas, se li oferirà la possibilitat de conèixer els resultats.  
PARTICIPACIÓ VOLUNTÀRIA 
La participació és voluntària i pot rebutjar o aturar la participació del seu fill/filla en 
qualsevol moment amb només expressar-ho verbalment.  
La seva decisió de deixar el seu fill/filla participar o no en l’estudi no influenciarà la 
qualitat de les cures mèdiques que el seu fill/filla té dret a rebre. 
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CONFIDENCIALITAT 
Els electrocardiogrames i les enquestes realitzades al seu fill/filla seran codificats, per 
tal d’assegurar la protecció de la seva identitat. El personal involucrat en la investigació 
no podrà identificar personalment a ningú a partir de l’anàlisi de l’electrocardiograma o 
les enquestes. La informació mèdica que es trobarà en l’informe de recerca del seu 
fill/filla en una base de dades en un ordinador, no permetrà la seva identificació. Les 
informacions donades a tercers (és a dir el personal de recerca o col·laboradors en 
l’estudi) tampoc ho permetran. Qualsevol dada de l’informe del seu fill/filla que permeti 
la seva identificació (el seu nom, número de pacient, adreça...) serà eliminat i 
reemplaçat per un codi de manera que no se li pugui identificar. Les dades del seu 
fill/filla poden ser publicats, però ell o ella no serà identificat pel nom. Així les dades i 
mostres del seu fill/filla es mantindran confidencials en tot moment. El Dr. Brugada, 
com a investigador principal d’aquest estudi, es compromet a garantir el compliment 
dels principis establers en la Llei Orgànica de caràcter personal 15/1999 i a facilitar els 
seus drets d’accés, rectificació, cancel·lació i oposició a les dades i/o 
electrocardiogrames. En cas que aquests fossin transferits a altres països, s’adoptaran les 
mesures necessàries per garantir la protecció de dades d’acord amb la legislació vigent a 
Espanya. 
RETRIBUCIONS 
El seu fill/filla no rebrà cap aportació econòmica per la seva participació en aquest 
estudi.  
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PROJECTE D’ESTUDI DE L’ELECTROCARDIOGRAMA EN ALUMNES DE 
2º D’ESO A LA COMUNA DE BANYOLES 
MENOR D’EDAT 
Investigador:  
Totes les meves preguntes sobre l’estudi s’han contestat satisfactòriament. 
Comprenc que puc retirar al meu fill/filla de l’estudi en qualsevol moment sense afectar 
les cures mèdiques que pugui requerir en un futur.  
Autoritzo a l’investigador a consultar l’informe mèdic del meu fill/filla i a guardar-lo 
dins d’un dossier d’investigació sense incloure dades que el/la identifiquin.   
Autoritzo a l’investigador a transmetre les dades i electrocardiograma al meu fill/filla a 
personal implicat en l’estudi sense incloure dades que l’identifiquin.  
He rebut una còpia d’aquest document i he tingut temps suficient abans d’accedir a que 
el meu fill/filla participin en aquest estudi.   
Desitjo que m’informin dels resultats de l’estudi del meu fill/filla quan estiguin 
disponibles.   
Si ___ No ___ 
_____________________________________________________Firma del pare/mare  
_________________________________________________Nom en lletra de impremta  
_____________________________________________________________Data i Hora 
____________________________________________________Nom del menor d’edat 
 
____________________________________________________Firma de l’investigador  
______________________________________________Nombre en lletra de impremta  
____________________________________________________________Data i Hora 
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                 13.2- Annex 2: Resolució del CEIC 
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13.3- Annex 3 
ENQUESTA SOBRE SÍMPTOMES I ANTECEDENTS FAMILIARS 
PROJECTE D'ESTUDI DE L'ELECTROCARDIOGRAMA EN ALUMNES DE 
2n D'ESO A LA COMUNA DE BANYOLES 
Respon a les següents preguntes marcant una creu a la casella corresponent:  
ANTECEDENTS FAMILIARES: 
1) Algú en la teva família va morir de manera sobtada (bruscament, sense cap 
avís)? 
  □Si  □No   
2) Quina relació tenies amb aquesta persona? 
  □ Era el meu pare/mare  
  □ Era el meu germà/germana  
  □ Era el meu tiet/a 
  □ Era el meu cosí/cosina   
  □ Era mi avi/a    
  □ Altres (explicar):  
………………………………………………………………………………………
……………………………………………………………………………………… 
3)  Quina edat tenia el teu familiar quan va morir sobtadament?...........anys.  
ANTECEDENTS PERSONALS 
1) Alguna vegada has sentit palpitacions (sensació que el teu cor batega ràpid i/o 
fort)? 
  □Sí  □No   
2) Alguna vegada has perdut el coneixement (desmaiar-te, caure al terra com 
adormit)? 
  □Si  □No   
3) Alguna vegada t'han dit que eres epilèptic o has tingut convulsions? 
 
  □Si  □No   
4) Prens algun tipus de medicació?  
 
  □Si  □No   
5)  Nom del/s medicament/s que prens: 
………………………………………………………………………………………
……………………………………………………………………………………… 
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13.4- Annex 4 
CRONOGRAMA DE TREBALL 
PROGRAMACIÓ ESTUDI ECG ANY 2010 
 
Data 
 
 
Hora 
 
Centre educatiu 
Dimarts 04-05-2010 
Dimecres 05-05-2010 
Dijous 06-05-2010 
Dilluns 10-05-2010 
Dimarts 11-05-2010 
Dijous 13-05-2010 
Dilluns 17-05-2010 
Dimarts 18-05-2010 
Dijous 20-05-2010 
Dilluns 24-05-2010 
15:00-17:00 
15:00-17:00 
15:30-17:30 
15:30-17:30 
15:00-17:00 
15:30-17:30 
15:30-17:30 
15:00-17:00 
15:30-17:30 
15:30-17:30 
IES Pla de l’Estany 
Escola Casa Nostra 
IES Pere Alsius i Torrent 
IES Josep Brugulat 
IES Pla de l’Estany 
IES Pere Alsius i Torrent 
IES Josep Brugulat 
IES Pla de l’Estany 
IES Pere Alsius i Torrent 
IES Josep Brugulat 
 
PROGRAMACIÓ ESTUDI ECG ANY 2011 
 
Data 
 
 
Hora 
 
Centre educatiu 
Dilluns 21-03-2011 
Dimarts 22-03-2011 
Dimecres 23-03-2011 
Dijous 24-03-2011 
Dilluns 28-03-2011 
Dimarts 29-03-2011 
Dijous 31-03-2011 
Dilluns 04-04-2011 
Dimarts 05-04-2011 
Dijous 07-04-2011 
15:30-17:30 
15:30-17:30 
15:00-17:00 
15:30-17:30 
15:30-17:30 
15:00-17:00 
15:30-17:30 
15:00-17:00 
15:00-17:00 
15:30-17:30 
IES Josep Brugulat 
IES Josep Brugulat 
Escola Casa Nostra 
IES Pere Alsius i Torrent 
IES Josep Brugulat 
IES Pla de l’Estany 
IES Pere Alsius i Torrent 
IES Pla de l’Estany 
IES Pla de l’Estany 
IES Pere Alsius i Torrent 
 
PROGRAMACIÓ ESTUDI ECG ANY 2012 
 
Data 
 
 
Hora 
 
Centre educatiu 
Dilluns 07-05-2012 
Dimarts 08-05-2012 
Dimecres 09-05-2012 
Dilluns 14-05-2012 
Dimarts 15-05-2012 
Dijous 17-05-2012 
15:00-17:00 
15:30-17:30 
15:00-17:00 
15:00-17:00 
15:30-17:30 
9:00-13:00 
IES Josep Brugulat 
IES Josep Brugulat 
Escola Casa Nostra 
IES Pere Alsius i Torrent 
IES Pere Alsius i Torrent 
IES Pla de l’Estany 
 
PROGRAMACIÓ ESTUDI ECG ANY 2013 
 
Data 
 
 
Hora 
 
Centre educatiu 
Dilluns 15-04-2013 
Dimarts 16-04-13 
Dimecres 17-04-13 
Dimecres 17-04-13 
Dijous 18-04-13 
13:00-15:00 
13:00-15:00 
9:30-13:50 
15:00-18:00 
9:00-13:00 
IES Josep Brugulat 
IES Josep Brugulat 
IES Pere Alsius i Torrent 
Escola Casa Nostra 
IES Pla de l’Estany 
 
